Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $2.83 Billion
- Q2 2024
A detailed history of Eco R1 Capital, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 11,607,425 shares of APLS stock, worth $325 Million. This represents 15.74% of its overall portfolio holdings.
Number of Shares
11,607,425
Previous 11,357,425
2.2%
Holding current value
$325 Million
Previous $668 Million
33.3%
% of portfolio
15.74%
Previous 19.04%
Shares
10 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
114MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$459 Million0.11% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$311 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$274 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$162 Million0.01% of portfolio
-
State Street Corp Boston, MA4.15MShares$116 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.07B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...